Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 19, 2024

SELL
$32.87 - $43.55 $4.99 Million - $6.61 Million
-151,877 Reduced 92.55%
12,233 $409,000
Q1 2024

Apr 24, 2024

BUY
$37.88 - $43.77 $5.92 Million - $6.84 Million
156,219 Added 1979.71%
164,110 $7.01 Million
Q4 2023

Jan 30, 2024

SELL
$31.71 - $38.95 $49,594 - $60,917
-1,564 Reduced 16.54%
7,891 $305,000
Q3 2023

Oct 23, 2023

SELL
$37.32 - $49.29 $229,406 - $302,985
-6,147 Reduced 39.4%
9,455 $356,000
Q2 2023

Jul 31, 2023

BUY
$39.98 - $47.68 $623,767 - $743,903
15,602 New
15,602 $710,000
Q1 2021

May 10, 2021

SELL
$76.38 - $86.03 $769,910 - $867,182
-10,080 Closed
0 $0
Q4 2020

Feb 12, 2021

BUY
$75.39 - $82.36 $2,035 - $2,223
27 Added 0.27%
10,080 $809,000
Q3 2020

Nov 04, 2020

BUY
$78.33 - $90.73 $96,032 - $111,234
1,226 Added 13.89%
10,053 $808,000
Q2 2020

Aug 07, 2020

BUY
$78.66 - $94.14 $1,809 - $2,165
23 Added 0.26%
8,827 $760,000
Q1 2020

Apr 29, 2020

SELL
$71.57 - $93.3 $19,896 - $25,937
-278 Reduced 3.06%
8,804 $715,000
Q4 2019

Feb 06, 2020

BUY
$76.7 - $88.45 $1,764 - $2,034
23 Added 0.25%
9,082 $759,000
Q3 2019

Nov 14, 2019

BUY
$81.4 - $89.78 $26,373 - $29,088
324 Added 3.71%
9,059 $792,000
Q2 2019

Aug 07, 2019

SELL
$73.44 - $82.41 $3,745 - $4,202
-51 Reduced 0.58%
8,735 $715,000
Q1 2019

Apr 29, 2019

BUY
$64.48 - $81.31 $566,521 - $714,389
8,786 New
8,786 $714,000
Q1 2019

Apr 18, 2019

SELL
$64.48 - $81.31 $559,106 - $705,039
-8,671 Closed
0 $0
Q3 2018

Nov 07, 2018

BUY
$70.71 - $77.75 $118,156 - $129,920
1,671 Added 23.87%
8,671 $668,000
Q2 2018

Aug 09, 2018

BUY
$63.43 - $75.41 $444,010 - $527,870
7,000 New
7,000 $517,000

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $14.9B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Dakota Wealth Management Portfolio

Follow Dakota Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dakota Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Dakota Wealth Management with notifications on news.